STADA Arzneimittel AG (STAGn.DE)
23 Nov 2017
* CEO says are confident that a profit and domination agreement with Elliott can be concluded at an EGM in Q1 2018 Further company coverage:
LONDON, Oct 3 Bankers are pitching debt financings of around €3bn-equivalent to back French private equity firm PAI Partners’ take private offer for Dutch juice bottling company Refresco, banking sources said on Tuesday.
LONDON, Sept 28 Over €5bn cleared Europe’s leveraged loan market via five jumbo deals in September and a further €5bn is set to launch from three more loans, illustrating the market's capacity to digest a number of sizeable transactions at the same time.
* dgap-news: bain capital and cinven announce appointment of five new supervisory board members at stada Source text for Eikon: Further company coverage: (Frankfurt newsroom)
* dgap-adhoc: stada arzneimittel ag: supervisory board of stada arzneimittel ag elects dr. Günter von au as new chairman Source text for Eikon: Further company coverage: (Frankfurt newsroom)
LONDON, Sept 27 UBS has hired Bruce MacKenzie as a managing director in EMEA leveraged capital markets (LCM), reporting to David Slade, the bank's global co-head of leveraged finance.
Sept 26 CVC Capital Partners and other private equity owners are exploring options for generic drugmaker Alvogen, including a sale, which could be valued at about $4 billion, Bloomberg reported on Tuesday.
LONDON, Sept 18 Europe's largest CLO managers are losing their influence over Europe's leveraged loan market as more diverse streams of money flows into the space.
LONDON, Sept 15 (IFR) - The bond portion of Stada's jumbo buyout financing backing its takeover by Bain Capital and Cinven finally hit screens on Friday morning.
* Says external law firm’s investigation of certain former execs didn't find evidence of self-enrichment, bribery or other criminal activity